Trial By Error, by David Tuller
-
A New Study from Exeter on “Brain Training” for Treatment of Post-Covid Cognitive Problems
The University of Exeter is now recruiting for a study of “brain training” as a treatment for prolonged cognitive dysfunction after a bout of Covid-19. I found out about this via a post on X. The post highlighted a message that had been sent to an unidentified patient from their medical providers: “Are you experiencing…
-
In England, Conflicts Between Families and Hospitals Threaten the Lives of Young Women with ME
ME patients and advocates in England have been alarmed by a series of ongoing cases in which the families of severely ill young women have struggled to convince hospitals to fit them with feeding tubes before they starve to death. I covered a similar situation last year in a piece about the life and death…
-
Another Letter Seeking Correction of Bogus “Clinically Effective” Claims from REGAIN Trial
Last month, I sent a letter to Dr Abbasi, the editor-in-chief of The BMJ, about an egregious and arguably fraudulent claim in the REGAIN trial—an investigation of a Long Covid physical and mental health rehabilitation program. Several other experts co-signed the letter. The journal asked us to send in a rapid response. We declined, on…
-
My Letter to Scientific Reports about New Study of Physical Activity and Long Covid
The other day I posted a blog about yet another problematic Long Covid study published by a major journal. The study concluded that physical activity (PA) can “reduce” symptoms in young women with prolonged medical complaints after Covid-19, or what the authors call post-COVID condition (PCC). The problem: the study design is capable of documenting…
-
Yet Another Long Covid Study with Bogus Claims Published by a Prestige Journal
I’ve recently spent some time lambasting a Long Covid study in The BMJ that claimed a rehab program addressing both physical and mental health was “clinically effective”—even though the primary outcome results fell below the recommended level for what would be considered “minimal clinically important difference” on the measure in question. Now another high impact…
-
My Letter to Lead REGAIN Trial Investigator Seeking Correction of Bogus Claims of Clinical Effectiveness
Two weeks ago, I sent a letter to The BMJ on behalf of myself and 12 colleagues seeking a correction in a study published last month. The study, called Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled trial,” claimed that the intervention under investigation had been…
-
We Asked BMJ to Correct a Paper; BMJ Requested a Rapid Response; We Have Declined
Leave a Comment / By David Tuller / 24 March 2024 Two weeks ago, I sent a letter to The BMJ on behalf of myself and 12 colleagues seeking a correction in a study published last month. The study, called Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled trial,” claimed…
-
David Putrino on 1) Australian Call to Scrap the Term “Long Covid” and 2) New Pre-Print on Sex Differences in LC
Last week, just in time for Long Covid Awareness Day on Friday, the chief health officer of the Australian state of Queensland, John Gerrard, declared that the term “Long Covid” should be dropped. He based his argument on Queensland survey data suggesting that rates of prolonged disability after Covid-19 are similar to those after other…
-
Professor Chris Ponting on the NIH’s Findings and the Latest on the Genome-Wide Association Study Update
When the US National Institutes of Health released its lengthy ME/CFS study last month with much fanfare and publicity, the London-based Science Media Centre asked Professor Chris Ponting, among other experts, to provide comment. The study–“Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome”–was published by Nature Communications. It included in-depth findings from 17 ME/CFS patients…
-
Guardian Columnist George Monbiot Calls Out the GET/CBT Charlatans and the Fraudulent PACE Trial
In a blistering take-down published on Tuesday, Guardian columnist George Monbiot indicted Professor Sir Simon Wessely, Professor Michael Sharpe and the rest of the GET/CBT ideological brigades for their decades-long promotion of discredited theories about and bogus research into the cluster of illnesses now being called ME/CFS. Those theories and research strategies reached their apotheosis,…
-
Letter to BMJ Seeking Correction in Study of Long Covid Physical-and-Mental Rehabilitation Program
Last month, The BMJ published a study of a rehab intervention for Long Covid in which the authors made claims that were not borne out by the data. The study was called “Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled…
-
Will MAGENTA’s Null Results Finally End Professor Crawley’s Long ‘Reign of Error’?
For years, Professor Esther Crawley, the University of Bristol’s methodologically and ethically challenged ME/CFS investigator, has hoovered up millions of pounds from public and private funders to support her misbegotten research. She achieved this success as a grant magnet despite abundant and easily available evidence that she was violating core principles of scientific research. Now,…